{
  "trial_id": "NCT03179410",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Karnofsky performance status, prior chemotherapy regimens, prior hormonal therapy, presence of liver metastases, serum PSA levels, serum LDH levels, ANC, hemoglobin, platelet count, creatinine levels, potassium levels, bilirubin levels, SGOT (AST) levels, SGPT (ALT) levels, presence of measurable disease, prior radiation therapy, life expectancy, prior use of abiraterone acetate, prior use of enzalutamide.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Karnofsky Performance Status Score",
          "Karnofsky performance status"
        ],
        [
          "Prior PSA",
          "serum PSA levels"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "prior chemotherapy regimens",
        "prior hormonal therapy",
        "presence of liver metastases",
        "serum LDH levels",
        "ANC",
        "hemoglobin",
        "platelet count",
        "creatinine levels",
        "potassium levels",
        "bilirubin levels",
        "SGOT (AST) levels",
        "SGPT (ALT) levels",
        "presence of measurable disease",
        "prior radiation therapy",
        "life expectancy",
        "prior use of abiraterone acetate",
        "prior use of enzalutamide"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Histologic subtype, Prior chemotherapy regimens, Karnofsky performance status, Baseline PSA levels, Baseline LDH levels, Baseline creatinine levels, Baseline hemoglobin levels, Baseline platelet count, Baseline ANC, Baseline liver function tests (AST, ALT, Bilirubin), Baseline potassium levels, Duration of metastatic disease, Prior radiation therapy, Prior hormonal therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Karnofsky Performance Status Score",
          "Karnofsky performance status"
        ],
        [
          "Prior PSA",
          "Baseline PSA levels"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Histologic subtype",
        "Prior chemotherapy regimens",
        "Baseline LDH levels",
        "Baseline creatinine levels",
        "Baseline hemoglobin levels",
        "Baseline platelet count",
        "Baseline ANC",
        "Baseline liver function tests (AST, ALT, Bilirubin)",
        "Baseline potassium levels",
        "Duration of metastatic disease",
        "Prior radiation therapy",
        "Prior hormonal therapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, Body Mass Index, Serum Total Testosterone, PSA, LDH, Hemoglobin, ANC, Platelet Count, Creatinine, Bilirubin, SGOT (AST), SGPT (ALT), Prior Chemotherapy Regimens, Prior Hormonal Therapy, Prior Radiation Therapy, Presence of Liver Metastases, Presence of Bulky Radiographic Progression.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Karnofsky Performance Status Score",
          "Karnofsky Performance Status"
        ],
        [
          "Prior PSA",
          "PSA"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Serum Total Testosterone",
        "LDH",
        "Hemoglobin",
        "ANC",
        "Platelet Count",
        "Creatinine",
        "Bilirubin",
        "SGOT (AST)",
        "SGPT (ALT)",
        "Prior Chemotherapy Regimens",
        "Prior Hormonal Therapy",
        "Prior Radiation Therapy",
        "Presence of Liver Metastases",
        "Presence of Bulky Radiographic Progression"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, Karnofsky performance status, race, ethnicity, weight, height, body mass index (BMI), serum total testosterone, PSA, LDH, hemoglobin, platelet count, ANC, creatinine, potassium, bilirubin, SGOT (AST), SGPT (ALT), presence of liver metastases, presence of bulky radiographic progression, prior use of chemotherapy, prior use of hormonal therapy, number of prior lines of therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Karnofsky Performance Status Score",
          "Karnofsky performance status"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Prior PSA",
          "PSA"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "serum total testosterone",
        "LDH",
        "hemoglobin",
        "platelet count",
        "ANC",
        "creatinine",
        "potassium",
        "bilirubin",
        "SGOT (AST)",
        "SGPT (ALT)",
        "presence of liver metastases",
        "presence of bulky radiographic progression",
        "prior use of chemotherapy",
        "prior use of hormonal therapy",
        "number of prior lines of therapy"
      ]
    }
  }
}